90
Participants
Start Date
March 1, 2024
Primary Completion Date
February 5, 2025
Study Completion Date
March 30, 2025
Bupivacaine 0.25%
At the end of gynecologic laparoscopic surgery and prior to trocar removal, 40 mL of Bupivacaine 0.25% is instilled intraperitoneal under direct vision to evaluate its analgesic effect.
Bupivacaine 0.25%
Before trocar insertion in gynecologic laparoscopic surgery, 5 mL of Bupivacaine 0.25% is infiltrated subcutaneously at each trocar port site to assess its effect on postoperative pain.
Faculty of Medicine, Cairo University, Cairo
Usama Ahmed Elsaeed Salem, MD
OTHER